Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 16, 2002Blood

Rituximab in the treatment of acquired factor VIII inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

AWAdrian WiestnerNational Institutes of HealthHCHearn Jay ChoTisch HospitalAAAdam S. AschOklahoma State University Oklahoma City

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Wiestner et al. (2002) studied this question.

synapsesocial.com/papers/6a7cc226178e986690cf899fhttps://doi.org/10.1182/blood-2002-03-0765
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura2001 · 551 citations
  2. 2Successful Treatment of Acquired Hemophilia with Oral Immunosuppressive Therapy1997 · 92 citations
  3. 3Acute Hepatitis B in a Patient with Antibodies to Hepatitis B Surface Antigen Who Was Receiving Rituximab2001 · 297 citations
  4. 4Corticosteroid Therapy for Acquired F VIII:C Inhibitors1981 · 107 citations
  5. 5A Survey of 215 Non-Hemophilic Patients with Inhibitors to Factor VIII1981 · 788 citations